PD Dr. Florian Putz

Department of Radiation Oncology

Volumetric assessment of paragangliomas of the head and neck following stereotactic radiotherapy (2018) Putz F, Weissmann T, Lettmaier S, Semrau S, Fietkau R Conference contribution The Role of local radical Therapy Approach in the metastatic Stage of Small Cell Lung Cancer (SCLC) (2018) Zoske H, Lettmaier S, Fietkau R, Putz F Conference contribution Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine (2018) Stritzelberger J, Distel L, Buslei R, Fietkau R, Putz F Journal article Brain volume after whole-brain radiotherapy: prognostic relevance and protective factors (2017) Putz F, Hoffmann C, Distel L, Gryc T, Knippen S, Fietkau R Conference contribution A semi-automatic Segmentation Pipeline for sequential Volumetric Analysis of intracranial Tumors (2017) Putz F, Knippen S, Fietkau R Conference contribution Volume Course of Acoustic Neuromas after stereotactic Radiotherapy (2017) Putz F, Lettmaier S, Knippen S, Gryc T, Fietkau R Conference contribution Locoregional recurrence in anal cancer: risk factors and management strategies (2017) Gryc T, Putz F, Merten R, Goerig N, Fietkau R, Strnad V Conference contribution One year survival of brain tumor patients is closely linked to symptomatic CMV-encephalopathy (2017) Goerig N, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt M, Dörfler A, et al. Conference contribution Erlangen Experience on radiosurgical Treatment for Trigeminal Neuralgia (2017) Lettmaier S, Putz F, Distel L, Bischoff B, Bozhkov Y, Merkel A, Lambrecht U, et al. Conference contribution Idelalisib may have the potential to increase radiotherapy side effects (2017) Gryc T, Putz F, Goerig N, Ziegler S, Fietkau R, Distel L, Schuster B Journal article